Assessment of hearing loss in multi-drug resistant tuberculosis (MDR-TB) patients undergoing Aminoglycoside treatment.

Simple item page
dc.contributor.authorNizamuddin, Sheikh
dc.contributor.authorKhan, Farhan Ahmad
dc.contributor.authorKhan, Abdur Rehman
dc.contributor.authorKamaal, Chand Miyan
dc.date.accessioned2015-11-26T11:31:55Z
dc.date.available2015-11-26T11:31:55Z
dc.date.issued2015-07
dc.description.abstractBackground: Incomplete treatments and treatment failures has led to Multi-drug resistant tuberculosis, which has emerged as a significant problem in treating tuberculosis and thus the second line drugs are used with the concomitant increase in the incidence of adverse effects. Methods: This prospective study was carried out from June 2009 to May 2014 in the department of ENT in collaboration with TB & Chest at Teerthanker Mahaveer Medical College & Research Centre. Out of 104, only 84 patients were included in our study. Patients were divided into three groups: group I (n=27) patients using Amikacin, group II (n=40) patients using kanamycin and group III (n=17) patients using streptomycin. Baseline pre-treatment pure tone audiometry was performed on all the patients and repeated every three months until completion of therapy. Results: Patients included were 15 to 55 years age with higher number of males (65%, n=55) than females (35%, n =29). Only 22.7% (n=19) of patients were found to be suffered from Hearing Loss. At the end of the study (at 12 month), Overall incidence of HFL was 58.0% (n=11) while incidence of Dead ear was 31.5% (n=6) and LFL was 10.5% (n=2). Amikacin was found to be more Ototoxic than Kanamycin and streptomycin. Conclusion: Aminoglycosides in MDR-TB patients may cause irreversible hearing loss involving higher frequencies and can become a hearing handicap as speech frequencies are too implied in more or less of the patients, thus underlining the need for regular audiologic evaluation in patients of MDR-TB during the treatment.en_US
dc.identifier.citationNizamuddin Sheikh, Khan Farhan Ahmad, Khan Abdur Rehman, Kamaal Chand Miyan. Assessment of hearing loss in multi-drug resistant tuberculosis (MDR-TB) patients undergoing Aminoglycoside treatment. International Journal of Research in Medical Sciences. 2015 July; 3(7): 1734-1740.en_US
dc.identifier.issn2320-6071
dc.identifier.issn2320-6012
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/166331
dc.language.isoenen_US
dc.source.urihttps://www.msjonline.org/?mno=189177en_US
dc.subjectTuberculosisen_US
dc.subjectMDR-TBen_US
dc.subjectAmikacinen_US
dc.subjectKanamycinen_US
dc.subjectStreptomycinen_US
dc.titleAssessment of hearing loss in multi-drug resistant tuberculosis (MDR-TB) patients undergoing Aminoglycoside treatment.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijrms2015v3n7p1734.pdf
Size:
308.48 KB
Format:
Adobe Portable Document Format
Description:
Research article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
International Journal of Research in Medical Sciences